Clinical Trial Update: Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating ranibizumab as adjuvant therapy for choroidal melanoma (Cohort 2) has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Melanoma

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: New England Retina Associates | Conditions: Choroidal Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2016-10-19